- PLN164.62m
- PLN126.93m
- PLN0.35m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.38 | ||
Price to Tang. Book | 2.41 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 470.34 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -22.31% | ||
Return on Equity | -23.87% | ||
Operating Margin | -5794% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | PLNm | 0.7 | 1.1 | 1 | 1.4 | 0.35 | 26.4 | 22.1 | -6.89% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The Company works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The Company is developing its own research center, which is intended as a basic location for conducting future research activities.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 15th, 2016
- Public Since
- November 23rd, 2021
- No. of Employees
- 33
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Warsaw Stock Exchange
- Shares in Issue
- 4,663,448

- Address
- Botaniczna 20, GDANSK, 80-298
- Web
- https://poltreg.tech/
- Phone
- Auditors
- UHY ECA Audyt Sp. Zoo SP. k.
Upcoming Events for PTG
Similar to PTG
Bioton SA
Warsaw Stock Exchange
Braster SA
Warsaw Stock Exchange
Captor Therapeutics SA
Warsaw Stock Exchange
Genomed SA
Warsaw Stock Exchange
Genomtec SA
Warsaw Stock Exchange
FAQ
As of Today at 22:41 UTC, shares in Poltreg SA are trading at PLN35.30. This share price information is delayed by 15 minutes.
Shares in Poltreg SA last closed at PLN35.30 and the price had moved by -30.31% over the past 365 days. In terms of relative price strength the Poltreg SA share price has underperformed the FTSE Global All Cap Index by -32.06% over the past year.
The overall consensus recommendation for Poltreg SA is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePoltreg SA does not currently pay a dividend.
Poltreg SA does not currently pay a dividend.
Poltreg SA does not currently pay a dividend.
To buy shares in Poltreg SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN35.30, shares in Poltreg SA had a market capitalisation of PLN164.62m.
Here are the trading details for Poltreg SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: PTG
Based on an overall assessment of its quality, value and momentum Poltreg SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Poltreg SA is PLN54.65. That is 54.82% above the last closing price of PLN35.30.
Analysts covering Poltreg SA currently have a consensus Earnings Per Share (EPS) forecast of -PLN2.55 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Poltreg SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -30.13%.
As of the last closing price of PLN35.30, shares in Poltreg SA were trading -21.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Poltreg SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN35.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Poltreg SA's directors